ArticleScience translational medicine2016

Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.

Saravanan S Karuppagounder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.